Skip to main content
Top
Published in: Journal of Neurology 9/2017

01-09-2017 | Original Communication

Early predictive factors of disability in CIDP

Authors: Emanuele Spina, Antonietta Topa, Rosa Iodice, Stefano Tozza, Lucia Ruggiero, Raffaele Dubbioso, Marcello Esposito, Dario Bruzzese, Lucio Santoro, Fiore Manganelli

Published in: Journal of Neurology | Issue 9/2017

Login to get access

Abstract

The objective of this study was to identify early clinical, biochemical and electrophysiological prognostic factors of disability in CIDP. We evaluated a dataset from 60 CIDP patients that included sex, age of onset, type of onset, phenotype, disease duration, response to treatment, disability at the time of diagnosis assessed using the modified Rankin Scale (baseline mRS), cerebrospinal fluid protein levels and electrophysiological data. All patients had clinical assessment of disability through the mRS within the last 6 months (last mRS) before enrollment in the study. Stepwise forward logistic regression model was applied to evaluate the impact of clinical, biochemical and electrophysiological parameters on the last mRS, considered as binary outcome (absence or presence of severe disability, i.e., <4/≥4 mRS). Moreover, we used Spearman’s rank correlation coefficient to evaluate the relationship between disease duration and last mRS. We observed a significant relationship between last mRS and baseline mRS [p = 0.015, z = 2.44, OR 5.15 (CI 1.38–19.22)] and age of onset [p = 0.017, z = 2.39, OR 1.13 (CI 1.02–1.27) per additional year of age of onset]. There was no correlation between disease duration and last mRS. Our data suggest that a worse clinical status at the beginning of disease and an older age at onset may be negative prognostic factors of long-term disability independent from disease duration.
Literature
1.
go back to reference Nobile-Orazio E (2014) Chronic inflammatory demyelinating polyradiculoneuropathy and variant: where we are and where we should go. J Periph Nerv Syst 19(1):2–13CrossRef Nobile-Orazio E (2014) Chronic inflammatory demyelinating polyradiculoneuropathy and variant: where we are and where we should go. J Periph Nerv Syst 19(1):2–13CrossRef
2.
go back to reference Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5):604–607CrossRefPubMed Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5):604–607CrossRefPubMed
3.
go back to reference Cocito D, Paolasso I, Antonini G, Benedetti L, Briani C, Comi C, Fazio R, Jann R, Matà S, Mazzeo A, Sabatelli M (2010) Nobile-Orazio E, on behalf of the Italian Network of CIDP Register. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 17(2):289–294. doi:10.1111/j.1468-1331.2009.02802.x CrossRefPubMed Cocito D, Paolasso I, Antonini G, Benedetti L, Briani C, Comi C, Fazio R, Jann R, Matà S, Mazzeo A, Sabatelli M (2010) Nobile-Orazio E, on behalf of the Italian Network of CIDP Register. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 17(2):289–294. doi:10.​1111/​j.​1468-1331.​2009.​02802.​x CrossRefPubMed
4.
go back to reference Gorson KC, Allam G, Ropper AH (1997) Chronich inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48:321–328CrossRefPubMed Gorson KC, Allam G, Ropper AH (1997) Chronich inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48:321–328CrossRefPubMed
5.
go back to reference Tackenberg B, Lünemann JD, Steinbrecher A, Rothenfusser-Korber E, Sailer M, Brück W, Schock S, Zschenderlein R, Zipp F, Sommer N (2007) Classification and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology 68(19):1622–1629CrossRefPubMed Tackenberg B, Lünemann JD, Steinbrecher A, Rothenfusser-Korber E, Sailer M, Brück W, Schock S, Zschenderlein R, Zipp F, Sommer N (2007) Classification and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology 68(19):1622–1629CrossRefPubMed
6.
go back to reference Querol L, Rojas-Garcia R, Casasnovas C, Sedano MJ, Muñoz-Blanco JL, Alberti MA, Paradas C, Sevilla T, Pardo J, Capablo JL, Sivera R, Guerrero A, Gutierrez-Rivas E, Illa I (2013) Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study. Muscle Nerve 48(6):870–876. doi:10.1002/mus.23843 CrossRefPubMed Querol L, Rojas-Garcia R, Casasnovas C, Sedano MJ, Muñoz-Blanco JL, Alberti MA, Paradas C, Sevilla T, Pardo J, Capablo JL, Sivera R, Guerrero A, Gutierrez-Rivas E, Illa I (2013) Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study. Muscle Nerve 48(6):870–876. doi:10.​1002/​mus.​23843 CrossRefPubMed
7.
go back to reference Bouchard C, Lacroix C, Plantè V, Adams D, Chedru F, Guglielmi JM, Said G (1999) Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52(3):498–503CrossRefPubMed Bouchard C, Lacroix C, Plantè V, Adams D, Chedru F, Guglielmi JM, Said G (1999) Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52(3):498–503CrossRefPubMed
8.
go back to reference Van Doorn PA, Vermeulen M, Brand A, Mulder PG, Busch HF (1991) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement. Arch Neurol 48(2):217–220CrossRefPubMed Van Doorn PA, Vermeulen M, Brand A, Mulder PG, Busch HF (1991) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement. Arch Neurol 48(2):217–220CrossRefPubMed
9.
go back to reference Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, van Doorn PA (2015) Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 86(12):1331–1336. doi:10.1136/jnnp-2014-309042 CrossRefPubMed Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, van Doorn PA (2015) Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 86(12):1331–1336. doi:10.​1136/​jnnp-2014-309042 CrossRefPubMed
10.
go back to reference Choudhary PP, Hughes RA (1995) Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. QJM 88(7):493–502PubMed Choudhary PP, Hughes RA (1995) Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. QJM 88(7):493–502PubMed
11.
go back to reference Hahn AF, Bolton CF, Zochodne D, Feasby TE (1996) Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled cross-over study. Brain 119(Pt.4):1067–1077CrossRefPubMed Hahn AF, Bolton CF, Zochodne D, Feasby TE (1996) Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled cross-over study. Brain 119(Pt.4):1067–1077CrossRefPubMed
12.
go back to reference Iijima M, Yamamoto M, Hirayama M, Tanaka F, Katsuno M, Mori K, Koike H, Hattori N, Arimura K, Nakagawa M (2005) Clinical ed electrophysiologic correlates of IVIg responsiveness in CIDP. Neurology 64(8):1471–1475CrossRefPubMed Iijima M, Yamamoto M, Hirayama M, Tanaka F, Katsuno M, Mori K, Koike H, Hattori N, Arimura K, Nakagawa M (2005) Clinical ed electrophysiologic correlates of IVIg responsiveness in CIDP. Neurology 64(8):1471–1475CrossRefPubMed
13.
go back to reference Iijima M, Tomita M, Morozumi S, Kawagashira Y, Nakamura T, Koike H, Katsuno M, Hattori N, Tanaka F, Yamamoto M, Sobue G (2009) Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP. Neurology 73(17):1348–1352. doi:10.1212/WNL.0b013e3181bd1139 CrossRefPubMed Iijima M, Tomita M, Morozumi S, Kawagashira Y, Nakamura T, Koike H, Katsuno M, Hattori N, Tanaka F, Yamamoto M, Sobue G (2009) Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP. Neurology 73(17):1348–1352. doi:10.​1212/​WNL.​0b013e3181bd1139​ CrossRefPubMed
14.
go back to reference Chiò A, Cocito D, Bottacchi E, Buffa C, Leone M, Plano F, Mutani R (2007) Calvo A, the PARCIDP. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Psychiatry 78(12):1349–1353CrossRefPubMedPubMedCentral Chiò A, Cocito D, Bottacchi E, Buffa C, Leone M, Plano F, Mutani R (2007) Calvo A, the PARCIDP. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Psychiatry 78(12):1349–1353CrossRefPubMedPubMedCentral
15.
go back to reference Kuwabara S, Misawa S, Mori M, Tanura M, Kubata M, Hattori T (2006) Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. J Neurol Neurosurg Psychiatry 77(1):66–70CrossRefPubMedPubMedCentral Kuwabara S, Misawa S, Mori M, Tanura M, Kubata M, Hattori T (2006) Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. J Neurol Neurosurg Psychiatry 77(1):66–70CrossRefPubMedPubMedCentral
16.
go back to reference Joint Task Force of the EFNS/PNS (2010) European Federation of Neurological Societes/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst. 15(1):1–9. doi:10.1111/j.1529-8027.2010-00245.x CrossRef Joint Task Force of the EFNS/PNS (2010) European Federation of Neurological Societes/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst. 15(1):1–9. doi:10.​1111/​j.​1529-8027.​2010-00245.​x CrossRef
17.
go back to reference Mygland A, Monstad P, Vedeler C (2005) Onset and course of chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 31(5):589–593CrossRefPubMed Mygland A, Monstad P, Vedeler C (2005) Onset and course of chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 31(5):589–593CrossRefPubMed
18.
19.
go back to reference Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D (2000) Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 21(1):31–37CrossRefPubMed Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D (2000) Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 21(1):31–37CrossRefPubMed
22.
go back to reference Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126(Pt. 4):770–782CrossRefPubMed Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126(Pt. 4):770–782CrossRefPubMed
23.
go back to reference Becker M, Latarche C, Roman E, Debouverie M, Malaplate-Armand C, Guillemin F (2015) No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients. BMC Neurol 13(15):79. doi:10.1186/s12883-015-0330-4 CrossRef Becker M, Latarche C, Roman E, Debouverie M, Malaplate-Armand C, Guillemin F (2015) No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients. BMC Neurol 13(15):79. doi:10.​1186/​s12883-015-0330-4 CrossRef
24.
go back to reference Amato MP, Ponziani G (2000) A prospective study on the prognosis of multiple sclerosis. Neurol Sci 21(4 Suppl 2):S831–S838CrossRefPubMed Amato MP, Ponziani G (2000) A prospective study on the prognosis of multiple sclerosis. Neurol Sci 21(4 Suppl 2):S831–S838CrossRefPubMed
26.
go back to reference Tedeholm H, Skoog B, Lisovskaja V, Runmarker B, Nrman O, Anderesn O (2015) The outcome spectrum of multiple sclerosis: disability, mortality and a cluster predictors from onset. J Neurol 262(5):1148–1163. doi:10.1007/s00415-015-7674-y CrossRefPubMed Tedeholm H, Skoog B, Lisovskaja V, Runmarker B, Nrman O, Anderesn O (2015) The outcome spectrum of multiple sclerosis: disability, mortality and a cluster predictors from onset. J Neurol 262(5):1148–1163. doi:10.​1007/​s00415-015-7674-y CrossRefPubMed
27.
go back to reference Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN (2013) Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 12:CD001797. doi:10.1002/14651858.CD001797 Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN (2013) Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 12:CD001797. doi:10.​1002/​14651858.​CD001797
28.
go back to reference Dyck PJ, Litchy WJ, Kratz KM, Kratz KM, Suarez GA, Low PA, Pineda AA, Windebank AJ, Karnes JL, O’Brien PC (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36(6):838–845CrossRefPubMed Dyck PJ, Litchy WJ, Kratz KM, Kratz KM, Suarez GA, Low PA, Pineda AA, Windebank AJ, Karnes JL, O’Brien PC (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36(6):838–845CrossRefPubMed
29.
go back to reference Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A, Inflammatory Neuropathy Cause and Treatment (INCAT) Group (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50(2):195–201CrossRefPubMed Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A, Inflammatory Neuropathy Cause and Treatment (INCAT) Group (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50(2):195–201CrossRefPubMed
30.
go back to reference Vermeulen M, van Doorn PA, Brand A, Strengers PF, Jennekens FG, Busch HF (1993) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 56(1):36–39CrossRefPubMedPubMedCentral Vermeulen M, van Doorn PA, Brand A, Strengers PF, Jennekens FG, Busch HF (1993) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 56(1):36–39CrossRefPubMedPubMedCentral
31.
go back to reference Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T (2002) Distribution pattern of demyelinating correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 72(1):37–42CrossRefPubMedPubMedCentral Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T (2002) Distribution pattern of demyelinating correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 72(1):37–42CrossRefPubMedPubMedCentral
Metadata
Title
Early predictive factors of disability in CIDP
Authors
Emanuele Spina
Antonietta Topa
Rosa Iodice
Stefano Tozza
Lucia Ruggiero
Raffaele Dubbioso
Marcello Esposito
Dario Bruzzese
Lucio Santoro
Fiore Manganelli
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 9/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8578-9

Other articles of this Issue 9/2017

Journal of Neurology 9/2017 Go to the issue

Pioneers in Neurology

Michael Kremer (1907–1988)